Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
33%(2 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
13
87%
Ph phase_4
2
13%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution15 total trials
Phase 4Post-market surveillance
2(13.3%)
N/ANon-phased studies
13(86.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(6)
Terminated(2)
Other(7)

Detailed Status

unknown7
Completed6
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (13.3%)
N/A13 (86.7%)

Trials by Status

terminated17%
unknown747%
withdrawn17%
completed640%

Recent Activity

Clinical Trials (15)

Drug Details

Intervention Type
DEVICE
Total Trials
15